These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 14512194

  • 1. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.
    Kato H, Furukawa K, Sato M, Okunaka T, Kusunoki Y, Kawahara M, Fukuoka M, Miyazawa T, Yana T, Matsui K, Shiraishi T, Horinouchi H.
    Lung Cancer; 2003 Oct; 42(1):103-11. PubMed ID: 14512194
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL, Juarez M, Allen R, Volz W, Albertson T.
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
    [Abstract] [Full Text] [Related]

  • 3. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW, Fingar VH, Coots CT, Wieman TJ.
    Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W, Liu Q, Nakagawa H, Sakaki H, Teh B, Matsumiya T, Yoshida H, Imaizumi T, Satoh K, Kimura H.
    Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic therapy (PDT) for lung cancers.
    Usuda J, Kato H, Okunaka T, Furukawa K, Tsutsui H, Yamada K, Suga Y, Honda H, Nagatsuka Y, Ohira T, Tsuboi M, Hirano T.
    J Thorac Oncol; 2006 Jun; 1(5):489-93. PubMed ID: 17409904
    [Abstract] [Full Text] [Related]

  • 6. Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter.
    Usuda J, Ichinose S, Ishizumi T, Hayashi H, Ohtani K, Maehara S, Ono S, Honda H, Kajiwara N, Uchida O, Tsutsui H, Ohira T, Kato H, Ikeda N.
    Clin Cancer Res; 2010 Apr 01; 16(7):2198-204. PubMed ID: 20332318
    [Abstract] [Full Text] [Related]

  • 7. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Nakagawa H, Matsumiya T, Sakaki H, Imaizumi T, Kubota K, Kusumi A, Kobayashi W, Kimura H.
    Oral Oncol; 2007 Jul 01; 43(6):544-50. PubMed ID: 17257889
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
    Katsumi TA, Aizawa K, Kuroiwa Y, Saito K, Kurata Y, Ii Y, Okunaka T, Konaka C, Kato H.
    Photochem Photobiol; 1996 Oct 01; 64(4):671-5. PubMed ID: 8863472
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T, Asakura T, Aihara H, Shiraki M, Takagi S, Kinouchi Y, Aizawa K, Shimosegawa T.
    Anticancer Res; 2003 Oct 01; 23(6C):4897-900. PubMed ID: 14981942
    [Abstract] [Full Text] [Related]

  • 10. Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy.
    Usuda J, Tsutsui H, Honda H, Ichinose S, Ishizumi T, Hirata T, Inoue T, Ohtani K, Maehara S, Imai K, Tsunoda Y, Kubota M, Ikeda N, Furukawa K, Okunaka T, Kato H.
    Lung Cancer; 2007 Dec 01; 58(3):317-23. PubMed ID: 17698240
    [Abstract] [Full Text] [Related]

  • 11. Management of multiple primary lung cancer in patients with centrally located early cancer lesions.
    Usuda J, Ichinose S, Ishizumi T, Hayashi H, Ohtani K, Maehara S, Ono S, Kajiwara N, Uchida O, Tsutsui H, Ohira T, Kato H, Ikeda N.
    J Thorac Oncol; 2010 Jan 01; 5(1):62-8. PubMed ID: 19952800
    [Abstract] [Full Text] [Related]

  • 12. [Development of a novel photosensitizer, talaporfin sodium, for the photodynamic therapy (PDT)].
    Tsukagoshi S, Tokyo Cooperative Oncology Group.
    Gan To Kagaku Ryoho; 2004 Jun 01; 31(6):979-85. PubMed ID: 15222124
    [Abstract] [Full Text] [Related]

  • 13. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ, Ferrario A.
    Cancer Res; 1990 Jul 01; 50(13):3985-90. PubMed ID: 2354446
    [Abstract] [Full Text] [Related]

  • 14. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S.
    Lasers Surg Med; 2001 Jul 01; 28(4):381-8. PubMed ID: 11344521
    [Abstract] [Full Text] [Related]

  • 15. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
    Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y.
    Nippon Ganka Gakkai Zasshi; 1997 Feb 01; 101(2):134-40. PubMed ID: 9124093
    [Abstract] [Full Text] [Related]

  • 16. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
    Nakamura H, Suzuki Y, Takeichi M, Saito T, Takayama M, Aizawa K.
    Int J Gynecol Cancer; 2002 Feb 01; 12(2):177-86. PubMed ID: 11975677
    [Abstract] [Full Text] [Related]

  • 17. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group.
    Furuse K, Fukuoka M, Kato H, Horai T, Kubota K, Kodama N, Kusunoki Y, Takifuji N, Okunaka T, Konaka C.
    J Clin Oncol; 1993 Oct 01; 11(10):1852-7. PubMed ID: 8410109
    [Abstract] [Full Text] [Related]

  • 18. Molecular determinants of photodynamic therapy for lung cancers.
    Usuda J, Ichinose S, Ishizumi T, Ohtani K, Inoue T, Maehara S, Imai K, Shima K, Ohira T, Kato H, Ikeda N.
    Lasers Surg Med; 2011 Sep 01; 43(7):591-9. PubMed ID: 22057486
    [Abstract] [Full Text] [Related]

  • 19. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM, Wang KK, Zinsmeister AR.
    Cancer; 1998 Jan 15; 82(2):421-7. PubMed ID: 9445202
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
    Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM.
    Retina; 2001 Jan 15; 21(5):499-508. PubMed ID: 11642380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.